Status:
COMPLETED
Flaxseed Consumption, Alone and in Combination With the Mediterranean-like Diet, on Some Indicators Related to Atherosclerosis
Lead Sponsor:
Javad Nasrollahzadeh
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Flaxseed consumption has beneficial effects on cardiovascular risk factors. In addition, the benefit of the Mediterranean-like diet in primary and secondary prevention of cardiovascular diseases has b...
Detailed Description
A randomized placebo controlled clinical trial will be conducted in Rajaie Cardiovascular Center in Tehran, Iran. After review of the inclusion and exclusion criteria and explanation of the design of ...
Eligibility Criteria
Inclusion
- coronary artery disease patients (more than 50% blockage in coronary arteries) needed angioplasty with stent
- willing to participation in the study
Exclusion
- cigarette Smoking
- continuous consumption of any antioxidant supplement such as vitamin E, vitamin C and Selenium in last month
- consumption of flaxseed or any omega-3 supplement at the beginning of the study
- َadvanced renal disease
- unwillingness to continuance
- any change in disease treatment plan such as change in type and dose of lipid lowering drugs or surgical operation
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT03392025
Start Date
September 1 2017
End Date
September 1 2018
Last Update
September 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajaie Cardiovascular, Medical & Research Center
Tehran, Iran